메뉴 건너뛰기




Volumn 35, Issue 3, 2007, Pages 981-982

Anti-inflammatory activity of albumin [3]

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CUPRIC ION; DIPEPTIDE; GAMMA INTERFERON; HETASTARCH; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

EID: 33947117747     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000257234.87784.91     Document Type: Letter
Times cited : (29)

References (5)
  • 1
    • 0037250851 scopus 로고    scopus 로고
    • Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia
    • Walley KR, McDonald TE, Wang Y, et al: Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia. Crit Care Med 2003; 31:187-194
    • (2003) Crit Care Med , vol.31 , pp. 187-194
    • Walley, K.R.1    McDonald, T.E.2    Wang, Y.3
  • 2
    • 0347363524 scopus 로고    scopus 로고
    • Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium
    • Lang JD Jr, Figueroa M, Chumley P, et al: Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 2004; 100:51-58
    • (2004) Anesthesiology , vol.100 , pp. 51-58
    • Lang Jr, J.D.1    Figueroa, M.2    Chumley, P.3
  • 3
    • 1542404992 scopus 로고    scopus 로고
    • Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury
    • Quinlan GJ, Mumby S, Martin GS, et al: Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32:755-759
    • (2004) Crit Care Med , vol.32 , pp. 755-759
    • Quinlan, G.J.1    Mumby, S.2    Martin, G.S.3
  • 4
    • 33744528587 scopus 로고    scopus 로고
    • Commercial human albumin preparations for clinical use are immunosuppressive in vitro
    • Bar-Or D, Thomas GW, Bar-Or R, et al: Commercial human albumin preparations for clinical use are immunosuppressive in vitro. Crit Care Med 2006; 34:1707-1712
    • (2006) Crit Care Med , vol.34 , pp. 1707-1712
    • Bar-Or, D.1    Thomas, G.W.2    Bar-Or, R.3
  • 5
    • 22144469136 scopus 로고    scopus 로고
    • Heterogeneity and oxidation status of commercial human albumin preparations in clinical use
    • Bar-Or D, Bar-Or R, Rael LT, et al: Heterogeneity and oxidation status of commercial human albumin preparations in clinical use. Crit Care Med 2005; 33:1638-1641
    • (2005) Crit Care Med , vol.33 , pp. 1638-1641
    • Bar-Or, D.1    Bar-Or, R.2    Rael, L.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.